TMS for drug-resistant epilepsy long-term study
Part of Brain & nervous system clinical trials.
This trial tests if transcranial magnetic stimulation (TMS, a non-invasive brain stimulation) targeting the cerebellum can safely reduce seizures over time in people with drug-resistant epilepsy. It aims to find a new treatment option for those whose seizures aren't controlled by medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have drug-resistant epilepsy (seizures not controlled by at least two medications).
- You have had drug-resistant epilepsy for at least 2 years.
- You have had at least 2 seizures per month in the last 3 months.
- You can undergo TMS (no metal implants in the head, no history of seizures triggered by magnetic stimulation, etc.).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a non-invasive brain stimulation technique (TMS) to target the cerebellum in people with Alzheimer's disease. It aims to see if this treatment can improve symptoms and cognitive function.
This study tests a new type of gentle brain stimulation (HD-tDCS) to see if it can reduce seizures in people with epilepsy that does not get better with standard medicines. The treatment uses a small device to send a weak electrical current to specific areas of the brain.
This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.
This study uses a special type of brain stimulation (transcranial magnetic stimulation, or TMS) to measure how well epilepsy medications are working in adults with epilepsy.
This trial tests an accelerated form of transcranial magnetic stimulation (TMS) for people with treatment-resistant depression who have been referred for ECT. It aims to offer a non-invasive, less intensive alternative with fewer side effects.
This study tests a type of brain stimulation called cTBS (continuous theta burst stimulation) applied to a specific part of the brain (the precuneus) to see if it helps with treatment-resistant depression. It aims to provide a new option for people who haven't found relief from standard treatments.
Hear when a new Drug Resistant Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.